NASDAQ:KALV

Kalvista Pharmaceuticals Stock Predictions

etoro logo Buy KALV
*Your capital is at risk
$26.95
+0.0100 (+0.0371%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KALV Prediction Chart

KALV Predictions History

Latest community submissions for KALV.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 8, 2025 $14.82 -1.61% $14.95 V 99.11% 3
rskfreespirit rskfreespirit Amateur
Jul 8, 2025 $17.48 +16.07% $14.95 X 83.08% 0
Feb 16, 2024 $15.21 +3.07% $14.86 V 97.62% 1
Feb 16, 2024 $15.04 +1.92% $14.86 V 98.77% 2
Feb 16, 2024 Bullish $14.86 V 1
JS JS Pro
Oct 7, 2022 $4.73 -4.06% $4.95 X 95.56% 0
Oct 5, 2022 Bullish $5.15 X 0
JS JS Pro
Oct 5, 2022 $7.10 +21.37% $5.15 X 62.14% 0
Oct 5, 2022 $6.54 +11.77% $5.15 X 73.04% 0
Oct 5, 2022 $13.21 +125.89% Unrealistic Excluded from avg $5.15 X 0.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KALV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KALVISTA PHARMACEUTICALS INC
KalVista Pharmaceuticals
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE